Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Sheraton Boston Hotel

14 ago 2017 7:30 a.m. - 17 ago 2017 5:00 p.m.

39 Dalton Street, , Boston, MA 02119 , USA

Regulatory Affairs: The IND, NDA, and Postmarketing

Session 13: Reporting Adverse Events (AEs) During Clinical Trials

Session Chair(s)

Elliott  Berger, PhD, MS

Elliott Berger, PhD, MS

President

ETB Regualtory Consulting, United States

  • Definitions of Terms
  • IND Safety Reports
  • IND Annual Reports - Safety Information
  • Discontinuation of Studies for Safety Reasons

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.